Evaluation of granulocyte-releasing products and chemiluminescence during cytapheresis.
During the procedures of centrifugation leukapheresis and plateletpheresis, donors occasionally experience adverse clinical reactions. The possibility of whether the activation of granulocytes and the subsequent release reactions, which may have been triggered by this extracorporeal circuit, were responsible for these adverse effects was evaluated. Six blood samples were obtained at set intervals during cytapheresis. Of these samples, four were taken directly from the donor. The remaining two were drawn from the efferent lines, i.e., those which return blood from the cytapheresis machine to the donor. Reactive oxygen species produced by granulocytes were measured by chemiluminescence (CL) using microamounts of whole blood or isolated granulocytes. Furthermore, secreted granulocyte products such as neutral proteinase elastase, which is present in plasma in a complex with alpha-1-proteinase inhibitor (E-alpha-1-PI), and lysosomal beta-glucuronidase were examined. A complete blood cell count and the values of hemoglobin, hematocrit, lactate dehydrogenase, protein, albumin, and proteinase inhibitors such as alpha-2-macroglobulin and alpha-1-proteinase inhibitor were also determined. Clinical chemical and cytologic values, with the exception of those for E-alpha-1-PI, were 10 to 17 percent lower than values before apheresis. These results can be attributed to inherent plasma volume expansion. Reduced CL was observed on the stimulation of phagocytes in the whole blood assay, as well as with stimulated granulocytes. Unstimulated granulocytes, on the other hand, showed an increased native CL. These data do not indicate a cytapheresis-mediated activation of the oxidative metabolism of granulocytes, and the concomitant discharge of proteolytic enzymes remains, therefore, of no clinical importance.
Lindena
J
J
Department of Clinical Biochemistry, Medical School, Hannover, FRG.
Sommerfeld
U
U
Burkhardt
H
H
Aulmann
H M
HM
D001772:Blood Cell Count; D001781:Blood Component Removal; D001798:Blood Proteins / Q000032:analysis; D006098:Granulocytes / Q000032:analysis* / Q000201:enzymology / Q000502:physiology; D006801:Humans; D007937:Leukapheresis; D008163:Luminescent Measurements; D010196:Pancreatic Elastase / Q000097:blood; D010983:Plateletpheresis; D011480:Protease Inhibitors / Q000097:blood; D012709:Serum Albumin / Q000032:analysis; D000515:alpha 1-Antitrypsin
D001798:Blood Proteins; D011480:Protease Inhibitors; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; D010196:Pancreatic Elastase